Ketamine for Cancer Pain

 

Ketamine for Cancer Pain Summary

Research into Ketamine for pain management shows it to be a safe alternative to opioids in emergency settings. A 2025 study has shown that 20-46% of patients achieved clinically meaningful improvements in pain management and found the benefits were sustained 6 months post treatment. A 2025 study found Ketamine to match the effect of opioids for immediate pain relief without the side effects. Overall the studies show that Ketamine is an effective tool for treating pain.

Cancer pain is typically categorized either as acute pain or chronic pain. Acute pain ranges from mild to severe and is characterized by sudden pain that occurs and goes away within a relatively brief amount of time. Chronic pain also ranges from mild to severe but either persists or progresses in severity over an extended period of time. Pain from cancer happens from the tumor pressing on bones/nerves/organs. Cancer treatments are usually a source of additional pain like chemotherapy, radiation therapy and surgery.

Ketamine helps dull the pain from both the cancer and the treatments. And best of all it does it quickly.

Note: Ketamine is FDA approved for general use in anesthesia and as of August 2025 it is approved for surgical pain management in perioperative settings.

1) Mechanism of Action

Ketamine is used as an analgesic, especially for severe acute pain and selected chronic pain syndromes.

  • NMDA receptor antagonism causes a reduction in glutamate-mediated pain transmission
  • Decreases central sensitization
  • Inhibits the wind-up phenomenon (progressive amplification of pain signals)
  • Enhances descending inhibitory pain pathways

These effects are especially relevant in neuropathic pain and opioid-resistant pain.

2) Clinical Indications

Acute pain

  • Trauma (including battlefield or emergency settings)
  • Postoperative pain
  • Burn pain
  • Severe acute pain requiring rapid control

Chronic pain

  • Neuropathic pain (for example, complex regional pain syndrome)
  • Cancer-related pain
  • Opioid-tolerant or opioid-resistant pain

Ketamine is often used as an adjunct rather than a first-line analgesic.

3) Clinical Effects

  • Rapid analgesia
  • Improved pain control in opioid-resistant cases
  • Reduction in hyperalgesia and allodynia
  • Decreased opioid requirements (opioid-sparing effect)
  • Improved quality of life in some patients

In chronic pain, ketamine may sometimes provide relief that lasts beyond the infusion period by helping reset abnormal pain processing.

4) Potential Advantages

  • Effective in opioid-resistant pain
  • Opioid-sparing, which may reduce opioid adverse effects and opioid dose requirements
  • Minimal respiratory depression
  • Useful in some hemodynamically unstable patients

These features make ketamine valuable in emergency, perioperative, and selected chronic pain settings.

5) Limitations and Risks

  • Variable response in chronic pain patients
  • Short duration of benefit in some cases
  • Need for monitoring at higher doses
  • Potential for misuse or dependence

6) Adverse Effects

  • Dissociation
  • Hallucinations or perceptual disturbances
  • Dizziness
  • Nausea/vomiting
  • Sedation
  • Increased blood pressure and heart rate

With repeated or long-term use

  • Cystitis (ketamine bladder syndrome)
  • Cognitive effects
  • Potential hepatotoxicity

7) Current Clinical Role

  • Used in palliative care and oncology pain management
  • Reserved for refractory cancer pain
  • Typically used as an adjunct to other analgesics